SAN DIEGO, CA--(Marketwired - Jul 31, 2013) - Bio-Matrix Scientific Group Inc. (OTCQB: BMSN) provided an update today on its subsidiary, Regen BioPharma's Investigational New Drug (IND) application ...
SAN DIEGO, CA--(Marketwired - Oct 9, 2013) - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) today announced that its Board of Directors has authorized a distribution on a pro rata basis as a dividend ...
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group’s (OTCBB:BMSN) announced today that it has retained a private grant research and development firm to aggressively pursue both private and public ...
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group (OTCBB:BMSN) Chairman and CEO David R. Koos gives his views about rolling out a new direction in stem cell banking by providing the first ...
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) and Its majority owned subsidiary Entest BioMedical Inc. (OTCBB: ENTB) announced today they have finalized a definitive ...
SAN DIEGO, Oct. 4, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) announced today the company has entered into discussions with several organizations regarding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback